| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA873491 | A | Pharmacokinetic profile in terms of half life was determined at a dose of 0.5 mg/kg administered intravenously in dog | Canis lupus familiaris | 2 | ALA1145764 | organism-based format | Scientific Literature | |
| 2. | ALA620954 | A | Pharmacokinetic profile in terms of half life was determined at a dose of 5 mg/kg administered intravenously in dog | Canis lupus familiaris | 1 | ALA1145764 | organism-based format | Scientific Literature | |
| 3. | ALA620955 | A | Plasma half life determined | Canis lupus familiaris | 1 | ALA1133294 | organism-based format | Scientific Literature | |
| 4. | ALA618097 | A | Plasma half life in dog | Canis lupus familiaris | 1 | ALA1128008 | organism-based format | Scientific Literature | |
| 5. | ALA618268 | A | Plasma half-life in Beagle dogs | Canis lupus familiaris | 1 | ALA1133808 | organism-based format | Scientific Literature | |
| 6. | ALA618269 | A | Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Beagle dog (male) | Canis lupus familiaris | 1 | ALA1135072 | organism-based format | Scientific Literature | |
| 7. | ALA618270 | A | Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg respectively in Beagle dog (male) | Canis lupus familiaris | 1 | ALA1135072 | organism-based format | Scientific Literature | |
| 8. | ALA618271 | A | Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in dog | Canis lupus familiaris | 2 | ALA1128104 | organism-based format | Scientific Literature | |
| 9. | ALA873493 | A | Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in dog | Canis lupus familiaris | 2 | ALA1128104 | organism-based format | Scientific Literature | |
| 10. | ALA621031 | A | Tested for the half life period in dog | Canis lupus familiaris | 20 | ALA1135057 | organism-based format | Scientific Literature | |
| 11. | ALA621032 | A | Tested for the half life period in dog at dosage of 10 mpk | Canis lupus familiaris | 3 | ALA1135057 | organism-based format | Scientific Literature | |
| 12. | ALA621033 | A | The compound was tested for half life in dog | Canis lupus familiaris | 1 | ALA1133315 | organism-based format | Scientific Literature | |
| 13. | ALA621034 | A | The compound was tested for time taken to decrease, half of its initial concentration in dog plasma. | Canis lupus familiaris | 2 | ALA1132849 | organism-based format | Scientific Literature | |
| 14. | ALA621035 | A | The half life was determined | Canis lupus familiaris | 2 | ALA1133315 | organism-based format | Scientific Literature | |
| 15. | ALA621036 | A | The plasma half-life in dogs | Canis lupus familiaris | 1 | ALA1133050 | organism-based format | Scientific Literature | |
| 16. | ALA621037 | A | suboptimal plasma half-life caused a10% prolongation of QTc interval in dogs at a plasma level of 2.5 M | Canis lupus familiaris | 1 | ALA1135455 | organism-based format | Scientific Literature | |
| 17. | ALA619812 | A | Half life in dog | Canis lupus familiaris | 1 | ALA1137087 | organism-based format | Scientific Literature | |
| 18. | ALA619813 | A | Pharmacokinetic property (t1/2beta) was measured in dog at the dose of 0.032 mg/kg i.v. | Canis lupus familiaris | 1 | ALA1136467 | organism-based format | Scientific Literature | |
| 19. | ALA873335 | A | tmax upon peroral administration of 10.0 mg/Kg dose in dog | Canis lupus familiaris | 2 | ALA1128104 | organism-based format | Scientific Literature | |
| 20. | ALA619814 | A | Volume of distribution in Beagle dogs after intravenous administration at a dose of 10 mg/kg | Canis lupus familiaris | 1 | ALA1135990 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!